Celltex News
Houston regenerative medicine leaders host delegation from Mexico
A blue ribbon delegation, composed of representatives from the offices of the Secretary of Health of Mexico, the Commission for the Protection against Sanitary Risk (COFEPRIS) — the equivalent of the U.S. FDA in Mexico — and The National Institute of Public Health Mexico (INSP) — the equivalent of the U.S. NIH in Mexico — recently spent two days in Houston and College Station. The purpose of their trip was to meet with leading researchers and doctors to explore the latest regenerative medicine advancements, specifically those using autologous mesenchymal stem cells. The visit was initiated by David Eller, CEO of Houston-based biotechnology company Celltex Therapeutics Corporation.
“We were honored to host these esteemed experts, who came to Houston to learn about our company,” says Eller. “We are excited about their expressed interest in establishing shared relationships with Celltex and other leaders in their respective fields who are using autologous stem cells to initiate technological breakthroughs in the accelerating field of regenerative medicine.”
PHOTO: The delegation visited Houston-based biotechnology company, Celltex. From left to right: Luis Ortiz Blas (INR); Dr. Ana Luisa Sesman Bernal (COFEPRIS); Julio Sánchez y Tépoz (COFEPRIS); José Clemente Ibarra Ponce de León (INR); Dr. Guillermo M. Ruiz-Palacios (INSP); David Eller (Celltex); Dr. Stan Jones (Celltex); Alejandro Sanders (INR); Erik Eller (Celltex)
The delegation met with Dr. Darwin J. Prockop, Director of the Institute for Regenerative Medicine, Texas A&M College of Medicine – Texas A&M University; Dr. Philip A. Salem, a physician, researcher, educator and international statesman in cancer medicine, and President of Salem Oncology Center in Houston; Dr. Mark Adickes, Chief of the Division of Sports Medicine at Baylor College of Medicine; Dr. Stanley Jones, Celltex Chief Medical Officer and Dr. Jane Young, Celltex Chief Scientific Officer, as well as other researchers from Houston’s regenerative medicine community.
Post Tags: business development
More Recent News
What Makes MSCs So Promising? A Deep Dive on Mesenchymal Stem Cells
Present in the body throughout one’s lifespan, adult Mesenchymal Stem Cells (MSCs) can be used in many types of regenerative medicine. This article explores how MSCs work in the body and what makes them suitable for therapeutic application.
Read MoreStem Cell Therapy: How Are MSCs Administered to the Body?
Through the years, several stem cell therapy delivery methods have emerged. This article explores some of the most common routes of administration physicians may recommend today.
Read More